76 results
Page 2 of 4
DEFR14A
u2660wn6l9j 5mbo
13 Nov 23
Revised proxy
5:15pm
DEF 14A
6j0ah76x6j9k
13 Nov 23
Definitive proxy
9:22am
PRE 14A
zcg222emw44uug6hbbhp
3 Nov 23
Preliminary proxy
4:04pm
10-K/A
qjvnk2wm0 ptia3sj1bo
5 Oct 23
Annual report (amended)
8:30pm
8-K
b5n 1ok98
3 Oct 23
Regulation FD Disclosure
7:00am
8-K
EX-99.1
u4d wodfdw
28 Sep 23
Renalytix Reports Full Year Fiscal 2023 Results
7:31am
S-3
cyi 8nts5kywongd
28 Sep 23
Shelf registration
6:58am
S-3
EX-4.3
683xn08ml7y6e
28 Sep 23
Shelf registration
6:58am
POS AM
7moqut90ix8davefd
28 Sep 23
Prospectus update (post-effective amendment)
6:55am
POS AM
cezmbolf317vpdzeu43
28 Sep 23
Prospectus update (post-effective amendment)
6:54am
10-K
lo3 bmy5kwpdwo3
28 Sep 23
Annual report
6:18am
10-K
EX-10.6
8w5yd
28 Sep 23
Annual report
6:18am
10-K
EX-10.7
urwimd
28 Sep 23
Annual report
6:18am
10-K
EX-10.8
kmsgb35 dg7
28 Sep 23
Annual report
6:18am
8-K
3wogr vphm3
22 Sep 23
Regulation FD Disclosure
7:00am
8-K
EX-99.1
zsbpvu1h
8 Sep 23
Renalytix Appoints Senior Executive Howard Doran as Chief Business Officer
4:04pm
8-K
40ml qpbt6zk
21 Aug 23
Regulation FD Disclosure
7:00am
8-K
EX-99.1
y5tyixm5sqz8wyk8h
3 Jul 23
Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors
2:30pm
6-K
EX-99.1
htw38g3xhv ot
30 Jun 23
Current report (foreign)
7:00am
6-K
ccdha4sb9jqdwjwr3
9 Jun 23
Current report (foreign)
7:01am